データなし
Revvity Announces An Expansion Of Its Work With Genomics England That Leverages Both Organizations' Expertise And Resources To Advance Critical Genomic Initiatives Across The United Kingdom
Scale Biosciences And Revvity's BioLegend Launch Solution For High Parameter Protein Profiling Of Single Cells; The TotalSeq Phenocyte Solution Supports Robust Study Of Cellular Heterogeneity And Rare Cell Types In Complex Samples At A Single Cell Level
Scale Biosciences and Revvity's BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells
Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference
Revvity Announces Investor Day For Nov. 21 And Updates Organizational Structure; Applied Genomics To Merge Into Life Sciences Solutions In Fiscal 2025, Streamlining Operations And Enhancing Customer Focus Across Key Markets
Press Release: Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation